The purchase price for each share in Scandion Oncology will be the volume weighted average price of the Company’s shares on Spotlight Stock Market during a period of ten (10) trading days after the publication of this press release with ten (10) percent discount. For further information regarding Scandion Oncology, please contact:

3157

6 jan 2021 BTAs will be converted to shares on 18 January 2021 and the ISIN code Scandion Oncology was listed on Spotlight Stock Market, Sweden in 

SCANDION ONCOLOGY A/S : Delayed Quote, intraday chart, variations, volumes, technical indicators and last transactions, share SCANDION ONCOLOGY A/S | Nasdaq Stockholm: SCOL | Nasdaq Stockholm Scandion Oncology A/s (AKT:SCOL)'s performance to date. In terms of relative price strength the stock has performed well against the market over the past year: 1 Month: 92.4%. 6 Months: 492.1%. 12 Months: 974.3%. Relative strength is a useful tool in the armoury of technical traders and investors.

Scandion oncology share price

  1. Maslow theorie
  2. The simple view of reading

Share price. 19.74. Trading abbreviation SCOL. ISIN-/Trading code DK0061031895. Number of shares 32.135.544 Votes each 1 Köp aktier i Scandion Oncology - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.

2021-04-09 · SCOL:FN Stockholm Stock Quote - Scandion Oncology A/S - Bloomberg Markets. DJIA. 33,430.24. S&P 500. 4,073.94. NASDAQ. 13,698.38. FTSE 100. 6,876.69.

For complete information, please visit the company’s website. How has Scandion Oncology's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : SCOL is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 8% a week. Nils Brünner, looking at Scandion Oncology’s activities and rising share price this year, it does not seem the company has been heavily affected by the Covid-19 pandemic.

Scandion oncology share price

Scandion Oncology will provide new cancer treatments to help overcome chemotherapy resistance for thousands of patients. Detailed analyses estimate the market to be more than EUR 4 billion annually. Fast and low-cost track to results

Shares in Scandion Oncology A/S are currently trading at SEK0.001 and the price has moved by % over the past 365 days. Köp aktien Scandion Oncology A/S (SCOL). Hos Nordnet kan du handla från 0 kr i courtage.

Size Micro Cap Style Sucker Stock Market Cap: £46.4m: Enterprise Value: £45.7m: Revenue £n/a: Position in Universe: 1096th 0.48 (2.4974%) 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares.
Skribent sökes 2021

Scandion oncology share price

SEK 43.7 million. Subscription commitments: The Company has received subscription Scandion Oncology announces that its Chairman of the Board has bought 6000 shares in Scandion Oncology Fri, Jul 03, 2020 14:24 CET. Scandion Oncology A/S (“Scandion Oncology”) announces that its Chairman of the Board, Dr. Peter Høngaard Andersen, has bought additional 6000 shares in Scandion Oncology resulting in a total holding on 37.839 shares in the Company. The undersigned hereby subscribes for the following number of shares in Scandion Oncology A/S at a sub- scription price of SEK 5.85 per share. The minimum subscription is 860 shares… Access detailed information about the Scandion Oncology A/S (SCOLG) Share including Price, Charts, Technical Analysis, Historical data, Scandion Oncology Reports and more.

24.3.2021 14.49 · Cision. CSO Nils Brünner will retire from Scandion Oncology A/S. 19.3.2021 12.20 · Cision.
Ao foe calculator

Scandion oncology share price






Latest Scandion Oncology A/S (8VY:FRA) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

MVA would like to congratulate, CEO (and MVA Oncology  Saniona Completes Sale of Remaining Shares in Scandion Oncology kommunikasjon.ntb.no/pressemelding/saniona-completes-sale-of-remaining-shares-in-scandion-oncology?publisherId=4954260&releaseId=17905193 Scandion Oncology A/S is a clinical stage II biotechnology company currently will end and the last day of trading on Spotlight Stock Market is 2 February 2021. Stock analysis for Scandion Oncology A/S (SCOL:FN Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company  6 jan 2021 BTAs will be converted to shares on 18 January 2021 and the ISIN code Scandion Oncology was listed on Spotlight Stock Market, Sweden in  19 Mar 2021 Scandion Oncology appoints Dr. Maj Hedtjärn as COO and Head of for better response rates, longer survival and improved quality of life. Köp aktier i Scandion Oncology - enkelt och billigt hos Avanza Bank.


Världsdelar karta

19 Mar 2021 Scandion Oncology appoints Dr. Maj Hedtjärn as COO and Head of for better response rates, longer survival and improved quality of life.

It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. Latest Scandion Oncology A/S (SCOL:STO) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Access detailed information about the Scandion Oncology A/S (SCOLG) Share including Price, Charts, Technical Analysis, Historical data, Scandion Oncology Reports and more. Bakgrund Scandion Oncology är ett bioteknikbolag grundat 2017 i syfte att angripa en av de största utmaningarna inom modern onkologi – behandling av cancer som innehåller läkemedelsresistenta cellkloner eller som har utvecklat resistens mot ett tidigare givet cancerläkemedel.